2004
DOI: 10.1097/01.mcp.0000134400.88832.9c
|View full text |Cite
|
Sign up to set email alerts
|

Interferon-induced granulomatous lung disease

Abstract: Interferon therapy can induce or exacerbate sarcoidosis, the disease disappears when interferon is discontinued, sometimes treatment with corticosteroids is required.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
19
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(19 citation statements)
references
References 28 publications
(27 reference statements)
0
19
0
Order By: Relevance
“…Some treatments may cause granulomatosis, such as BCG therapy for treatment of bladder cancer, interferon alfa and beta for treatment of malignant melanoma, IL-2 for renal cell carcinoma, or methotrexate (18).…”
Section: Discussionmentioning
confidence: 99%
“…Some treatments may cause granulomatosis, such as BCG therapy for treatment of bladder cancer, interferon alfa and beta for treatment of malignant melanoma, IL-2 for renal cell carcinoma, or methotrexate (18).…”
Section: Discussionmentioning
confidence: 99%
“…IFN-alpha and IFN-beta can activate antigen-presenting cells and stimulate them to release proinflammatory cytokines such as IL-12, TNF apha and IFN gamma. Recent studies have shown that IFN-alpha also stimulates NK cells to produce IFN-gamma, leading to Th1 differentiation and reducing Th2 cell activation [10,15,18,26,37]. Stimulated Th1 cells activate macrophages and enhance the differentiation of mononuclear cells into epitheloid cells and the granuloma formation.…”
Section: Discussionmentioning
confidence: 99%
“…Management includes the discontinuation of IFN therapy with or without the administration of systemic corticosteroids [12]. Most patients will have complete resolution of the disease within a few months of discontinuing interferon therapy, without the need for immunosuppressants [13]. The prognosis for IFN-alpha-induced sarcoidosis is very good, with improvement once medication is discontinued [14].…”
Section: Discussionmentioning
confidence: 99%